Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Transtema in connection with a directed share issue
Mandate

Vinge has advised Transtema in connection with a directed share issue

March 10, 2023 Capital Markets and Public M&A

Vinge has advised Trantema Group AB (Nasdaq Stockholm) in connection with a directed share issue of approximately SEK 63 million.

The subscription price was determined through an accelerated bookbuilding procedure and the shares were allocated to a number of Swedish and international institutional investors.

Vinge's team consisted of Anders Strid and Edin Agic.

Related

Vinge advises Oncorena in connection with share issue

 Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025

Vinge advises Karl Hedin and minority owners on the sale of AB Karl Hedin Sågverk to Vida

 Vinge has advised Karl Hedin and minority shareholders in connection with the sale of AB Karl Hedin Sågverk to Vida Aktiebolag (“Vida”).
July 24, 2025

Vinge advises OsteoCentric on the public offer for Integrum

 OsteoCentric Oncology and Bone Anchored Prostheses, LLC, a subsidiary of OsteoCentric Technologies, Inc., has made a public offer for all shares in Integrum AB (publ). The offer values all shares in Integrum at approximately SEK 939 million.
July 23, 2025